NEW YORK — Phase Genomics said on Tuesday that it has been awarded a $1.7 million grant from the National Institutes of Health to support its development of a platform for discovery of novel viruses that can be used to develop new therapeutics.
With the funding, Phase Genomics aims to use its sequencing-based proximity ligation, or Hi-C, technology to develop a reagent kit and accompanying analytical software for the culture-free assembly of viral genomes from metagenomic samples and associate these viruses with their microbial hosts.